Edwin Jonathan Tucker - 04 Jun 2025 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Chief Medical Officer
Signature
By: /s/ Herb Cross, as Attorney-in-Fact
Issuer symbol
JSPR
Transactions as of
04 Jun 2025
Net transactions value
$0
Form type
4
Filing time
06 Jun 2025, 06:23:17 UTC
Previous filing
18 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tucker Edwin Jonathan Chief Medical Officer C/O JASPER THERAPEUTICS, INC., 2200 BRIDGE PKWY, SUITE #102, REDWOOD CITY By: /s/ Herb Cross, as Attorney-in-Fact 06 Jun 2025 0001792296

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JSPR Stock Option (right to buy) Award $0 +90,000 $0.000000 90,000 04 Jun 2025 Voting Common Stock 90,000 $6.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the retention option shall vest on June 4, 2026 and 1/48th of the shares subject to the retention option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.